Clinical Trial Tests Efficacy of Anti-Inflammatory Drug to Treat People With COVID-19: NYU Langone Health
April 16, 2020
April 16, 2020
NEW YORK, April 16 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
A new clinical trial seeks to determine whether the common anti-inflammatory medication colchicine can help decrease the progression of disease in people with coronavirus disease 2019 (COVID-19).
Co-led by clinician-researchers at NYU Langone Health and the Montreal Heart Institute Research Centre, the new COLCORONA trial will inve . . .
A new clinical trial seeks to determine whether the common anti-inflammatory medication colchicine can help decrease the progression of disease in people with coronavirus disease 2019 (COVID-19).
Co-led by clinician-researchers at NYU Langone Health and the Montreal Heart Institute Research Centre, the new COLCORONA trial will inve . . .